Drugs / Fluval P
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT01100294 | Sep 2009 → Apr 2010 | influenza | Fluart Innovative Vaccine Ltd, Hungary | Completed | No outcome recorded |
| — | NCT01407978 | Aug 2009 → Mar 2010 | swine influenza | Fluart Innovative Vaccine Ltd, Hungary | Completed | No outcome recorded |
| — | NCT01010893 | Aug → Sep 2009 | influenza | Fluart Innovative Vaccine Ltd, Hungary | Completed | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fluval P | “This is an open, uncontrolled study to assess safety and tolerability of Fluval P monovalent influenza vaccine (whole virus, inactivated, adjuvanted with alumn phosphate gel)...” NCT01100294 ↗ |
| Modality | Vaccine | “whole-virion, inactivated, adjuvanted pandemic H1N1 vaccine” PMID 20018367 ↗ Dec 2009 |